Neuroscience Strategic Roundup | June17–July 21, 2026
Strategic Developments and Competitive Shifts in Neuroscience Coverage Period:…
Lucid Diligence Brief: Syremis Therapeutics launches with $165M Series A in schizophrenia
Lucid Diligence Brief: Syremis Therapeutics launches with $165M Series A in…

